Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targeting

Journal of Molecular Biology

Volumn 405, Issue 2, 2011, Pages 410-426

  Dreier, Birgit ^a   Mikheeva, Galina ^b   Belousova, Natalya ^b   Parizek, Petra ^a   Boczek, Edgar ^a   Jelesarov, Ilian ^a   Forrer, Patrik ^a   Plückthun, Andreas ^a   Krasnykh, Victor ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

affinity; DARPins; knob; targeted gene delivery; viral vectors

Indexed keywords

ADENOVIRUS VECTOR; ANKYRIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADENOVIRUS; ARTICLE; CELL SURFACE; ESCHERICHIA COLI; FIBER; GENE TARGETING; GENE TRANSFER; GENE VECTOR; HUMAN; HUMAN CELL; PLANT GROWTH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PURIFICATION; RIBOSOME; STOICHIOMETRY; VIRION; VIRUS ATTACHMENT;

ADENOVIRIDAE; ESCHERICHIA COLI;

EID: 78650875585     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.10.040     Document Type: Article

References (77)

1. Amalfitano A., and Parks R.J. Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy Curr. Gene Ther. 2 2002 111 133
2. Barouch D.H., Pau M.G., Custers J.H., Koudstaal W., Kostense S., and Havenga M.J. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity J. Immunol. 172 2004 6290 6297
3. Kobinger G.P., Feldmann H., Zhi Y., Schumer G., Gao G., and Feldmann F. Chimpanzee adenovirus vaccine protects against Zaire Ebola virus Virology 346 2006 394 401
4. Sullivan N.J., Geisbert T.W., Geisbert J.B., Xu L., Yang Z.Y., and Roederer M. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates Nature 424 2003 681 684
5. Burton J.B., Johnson M., Sato M., Koh S.B., Mulholland D.J., and Stout D. Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer Nat. Med. 14 2008 882 888
6. Kishimoto H., Zhao M., Hayashi K., Urata Y., Tanaka N., and Fujiwara T. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation Proc. Natl Acad. Sci. USA 106 2009 14514 14517
7. Roberts D.M., Nanda A., Havenga M.J., Abbink P., Lynch D.M., and Ewald B.A. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity Nature 441 2006 239 243
8. McConnell M.J., Danthinne X., and Imperiale M.J. Characterization of a permissive epitope insertion site in adenovirus hexon J. Virol. 80 2006 5361 5370
9. Worgall S., Krause A., Rivara M., Hee K.K., Vintayen E.V., and Hackett N.R. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid J. Clin. Invest. 115 2005 1281 1289
10. Le L.P., Everts M., Dmitriev I.P., Davydova J.G., Yamamoto M., and Curiel D.T. Fluorescently labeled adenovirus with pIX-EGFP for vector detection Mol. Imaging 3 2004 105 116
11. Li J., Le L., Sibley D.A., Mathis J.M., and Curiel D.T. Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion Virology 338 2005 247 258
12. Krasnykh V.N., Douglas J.T., and van Beusechem V.W. Genetic targeting of adenoviral vectors Mol. Ther. 1 2000 391 405
13. Nicklin S.A., Wu E., Nemerow G.R., and Baker A.H. The influence of adenovirus fiber structure and function on vector development for gene therapy Mol. Ther. 12 2005 384 393
14. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., and Hong J.S. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 Science 275 1997 1320 1323
15. Tomko R.P., Xu R., and Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses Proc. Natl Acad. Sci. USA 94 1997 3352 3356
16. Wickham T.J., Mathias P., Cheresh D.A., and Nemerow G.R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment Cell 73 1993 309 319
17. Arnberg N., Edlund K., Kidd A.H., and Wadell G. Adenovirus type 37 uses sialic acid as a cellular receptor J. Virol. 74 2000 42 48
18. Gaggar A., Shayakhmetov D.M., and Lieber A. CD46 is a cellular receptor for group B adenoviruses Nat. Med. 9 2003 1408 1412
19. Short J.J., Pereboev A.V., Kawakami Y., Vasu C., Holterman M.J., and Curiel D.T. Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors Virology 322 2004 349 359
20. Chroboczek J., Ruigrok R.W., and Cusack S. Adenovirus fiber Curr. Top. Microbiol. Immunol. 199 1995 163 200
21. Novelli A., and Boulanger P.A. Assembly of adenovirus type 2 fiber synthesized in cell-free translation system J. Biol. Chem. 266 1991 9299 9303
22. Hong J.S., and Engler J.A. Domains required for assembly of adenovirus type 2 fiber trimers J. Virol. 70 1996 7071 7078
23. Novelli A., and Boulanger P.A. Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber Virology 185 1991 365 376
24. Wickham T.J., Tzeng E., Shears L.L. II, Roelvink P.W., Li Y., and Lee G.M. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins J. Virol. 71 1997 8221 8229
25. Magnusson M.K., Hong S.S., Henning P., Boulanger P., and Lindholm L. Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability J. Gen. Med. 4 2002 356 370
26. Chen C.Y., May S.M., and Barry M.A. Targeting adenoviruses with factor x-single-chain antibody fusion proteins Hum. Gene Ther. 21 2010 739 749
27. Dmitriev I., Kashentseva E., Rogers B.E., Krasnykh V., and Curiel D.T. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells J. Virol. 74 2000 6875 6884
28. Ebbinghaus C., Al-Jaibaji A., Operschall E., Schoffel A., Peter I., Greber U.F., and Hemmi S. Functional and selective targeting of adenovirus to high-affinity Fcγ receptor I-positive cells by using a bispecific hybrid adapter J. Virol. 75 2001 480 489
29. 3 integrins, VEGFR2 and Tie2 endothelial receptors by angio-adenobodies Int. J. Pharm. 391 2010 155 161
30. Hong S.S., Galaup A., Peytavi R., Chazal N., and Boulanger P. Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificity Hum. Gene Ther. 10 1999 2577 2586
31. Korokhov N., Mikheeva G., Krendelshchikov A., Belousova N., Simonenko V., and Krendelshchikova V. Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge J. Virol. 77 2003 12931 12940
32. Pereboev A.V., Nagle J.M., Shakhmatov M.A., Triozzi P.L., Matthews Q.L., and Kawakami Y. Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule Mol. Ther. 9 2004 712 720
33. Reynolds P.N., Zinn K.R., Gavrilyuk V.D., Balyasnikova I.V., Rogers B.E., and Buchsbaum D.J. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo Mol. Ther 2 2000 562 578
34. Watkins S.J., Mesyanzhinov V.V., Kurochkina L.P., and Hawkins R.E. The 'adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery Gene Ther. 4 1997 1004 1012
35. Wickham T.J., Segal D.M., Roelvink P.W., Carrion M.E., Lizonova A., Lee G.M., and Kovesdi I. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies J. Virol 70 1996 6831 6838
36. Chen C.Y., and Barry M.A. FX domain fused to single-chain antibodies improve oncolytic effect of Ad5 In vitro and In vivo 13th Annual Meeting of American Society of Gene and Cell Therapy, Washington, DC, USA 2010
37. Binz H.K., Amstutz P., Kohl A., Stumpp M.T., Briand C., and Forrer P. High-affinity binders selected from designed ankyrin repeat protein libraries Nat. Biotechnol. 22 2004 575 582
38. Binz H.K., Stumpp M.T., Forrer P., Amstutz P., and Plückthun A. Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins J. Mol. Biol. 332 2003 489 503
39. Steiner D., Forrer P., and Plückthun A. Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display J. Mol. Biol. 382 2008 1211 1227
40. Wetzel S.K., Settanni G., Kenig M., Binz H.K., and Plückthun A. Folding and unfolding mechanism of highly stable full-consensus ankyrin repeat proteins J. Mol. Biol. 376 2008 241 257
41. Roelvink P.W., Mi Lee G., Einfeld D.A., Kovesdi I., and Wickham T.J. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae Science 286 1999 1568 1571
42. Zahnd C., Wyler E., Schwenk J.M., Steiner D., Lawrence M.C., and McKern N.M. A designed ankyrin repeat protein evolved to picomolar affinity to Her2 J. Mol. Biol. 369 2007 1015 1028
43. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., and McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177 182
44. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., and Keith D.E. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 1989 707 712
45. Theurillat J.P., Dreier B., Nagy-Davidescu G., Seifert B., Behnke S., and Zurrer-Hardi U. Designed ankyrin repeat proteins: a novel tool for testing epidermal growth factor receptor 2 expression in breast cancer Mod. Path. 23 2010 1289 1297
46. Winkler J., Martin-Killias P., Plückthun A., and Zangemeister-Wittke U. EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins Mol. Cancer Ther. 9 2009 2674 2683
47. Zahnd C., Kawe M., Stumpp M.T., de Pasquale C., Tamaskovic R., and Nagy-Davidescu G. Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size Cancer Res. 70 2010 1595 1605
48. Veesler D., Dreier B., Blangy S., Lichière J., Tremblay D., Moineau S., Spinelli S., Tegoni M., Plückthun A., Campanacci V., and Cambillau C. Crystal structure of a DARPin neutralizing inhibitor of lactococcal phage TP901-1: comparison of DARPin and camelid VHH binding mode J. Biol. Chem. 384 2009 30718 30726
49. Wen J., and Arakawa T. Refractive index of proteins in aqueous sodium chloride Anal. Biochem. 280 2000 327 329
50. Wen J., Arakawa T., and Philo J.S. Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions Anal. Biochem. 240 1996 155 166
51. Zlotnick A., and Stray S.J. How does your virus grow? Understanding and interfering with virus assembly Trends Biotechnol. 21 2003 536 542
52. Forrer P., Chang C., Ott D., Wlodawer A., and Plückthun A. Kinetic stability and crystal structure of the viral capsid protein SHP J. Mol. Biol. 344 2004 179 193
53. Alba R., Bradshaw A.C., Parker A.L., Bhella D., Waddington S.N., and Nicklin S.A. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer Blood 114 2009 965 971
54. Belousova N., Korokhov N., Krendelshchikova V., Simonenko V., Mikheeva G., and Triozzi P.L. Genetically targeted adenovirus vector directed to CD40-expressing cells J. Virol. 77 2003 11367 11377
55. Belousova N., Mikheeva G., Gelovani J., and Krasnykh V. Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer J. Virol. 82 2008 630 637
56. Krasnykh V.N., Mikheeva G.V., Douglas J.T., and Curiel D.T. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism J. Virol. 70 1996 6839 6846
57. Plückthun A., and Pack P. New protein engineering approaches to multivalent and bispecific antibody fragments Immunotechnology 3 1997 83 105
58. Presta L.G. Molecular engineering and design of therapeutic antibodies Curr. Opin. Immunol. 20 2008 460 470
59. Müller D., and Kontermann R.E. Recombinant bispecific antibodies for cellular cancer immunotherapy Curr. Opin. Mol. Ther. 9 2007 319 326
60. Marvin J.S., and Zhu Z. Recombinant approaches to IgG-like bispecific antibodies Acta Pharmacol. Sin. 26 2005 649 658
61. Fischer N., and Leger O. Bispecific antibodies: molecules that enable novel therapeutic strategies Pathobiology 74 2007 3 14
62. Amstutz P., Koch H., Binz H.K., Deuber S.A., and Plückthun A. Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries Protein Eng. Des. Sel. 19 2006 219 229
63. Milovnik P., Ferrari D., Sarkar C.A., and Plückthun A. Selection and characterization of DARPins specific for the neurotensin receptor 1 Protein Eng. Des. Sel. 22 2009 357 366
64. Schweizer A., Roschitzki-Voser H., Amstutz P., Briand C., Gulotti-Georgieva M., and Prenosil E. Inhibition of caspase-2 by a designed ankyrin repeat protein: specificity, structure, and inhibition mechanism Structure 15 2007 625 636
65. Wang H., Liu Y., Li Z., Tuve S., Stone D., and Kalyushniy O. In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46 J. Virol. 82 2008 10567 10579
66. Alba R., Bradshaw A.C., Coughlan L., Denby L., McDonald R.A., and Waddington S.N. Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors Blood 116 2010 2656 2664
67. Gensler M., Buschbeck M., and Ullrich A. Negative regulation of HER2 signaling by the PEST-type protein-tyrosine phosphatase BDP1 J. Biol. Chem. 279 2004 12110 12116
68. Zahnd C., Amstutz P., and Plückthun A. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target Nat. Methods 4 2007 269 279
69. Hanes J., and Plückthun A. In vitro selection and evolution of functional proteins by using ribosome display Proc. Natl Acad. Sci. USA 94 1997 4937 4942
70. Dreier B., and Plückthun A. Ribosome display, a technology for selecting and evolving proteins from large libraries D. Park, PCR Protocols 3rd edit. 2010 Humana Press New York, NY
71. Luginbühl B., Kanyo Z., Jones R.M., Fletterick R.J., Prusiner S.B., and Cohen F.E. Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretation J. Mol. Biol. 363 2006 75 97
72. Zahnd C., Sarkar C.A., and Plückthun A. Computational analysis of off-rate selection experiments to optimize affinity maturation by directed evolution Protein Eng. Des. Sel. 23 2010 175 184
73. Hanes J., Jermutus L., Weber-Bornhauser S., Bosshard H.R., and Plückthun A. Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries Proc. Natl Acad. Sci. USA 95 1998 14130 14135
74. Zahnd C., Spinelli S., Luginbühl B., Amstutz P., Cambillau C., and Plückthun A. Directed in vitro evolution and crystallographic analysis of a peptide binding scFv antibody with low picomolar affinity J. Biol. Chem. 279 2004 18870 18877
75. Jelesarov I., and Bosshard H.R. Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition J. Mol. Recognit. 12 1999 3 18
76. Krasnykh V., Belousova N., Korokhov N., Mikheeva G., and Curiel D.T. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin J. Virol. 75 2001 4176 4183
77. Chartier C., Degryse E., Gantzer M., Dieterle A., Pavirani A., and Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli J. Virol. 70 1996 4805 4810